FOUR-DIMENSIONAL POSITRON EMISSION TOMOGRAPHY: IMPLICATIONS FOR DOSE PAINTING OF HIGH-UPTAKE REGIONS

被引:23
作者
Aristophanous, Michalis [1 ,2 ]
Yap, Jeffrey T. [2 ,3 ]
Killoran, Joseph H. [1 ,2 ]
Chen, Aileen B. [1 ,2 ]
Berbeco, Ross I. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 80卷 / 03期
关键词
4D PET/CT; Dose painting; Biological target volume; Lung cancer; LUNG-CANCER; FDG-PET; RADIOTHERAPY; DEFINITION; IMPACT;
D O I
10.1016/j.ijrobp.2010.08.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the behavior of tumor subvolumes of high [18F]-fluorodeoxyglucose (FDG) uptake as seen on clinical four-dimensional (4D) FDG-positron emission tomography (PET) scans. Methods and Materials: Four-dimensional FDG-PET/computed tomography scans from 13 patients taken before radiotherapy were available. The analysis was focused on regions of high uptake that are potential dose-painting targets. A total of 17 lesions (primary tumors and lymph nodes) were analyzed. On each one of the five phases of the 4D scan a classification algorithm was applied to obtain the region of highest uptake and segment the tumor volume. We looked at the behavior of both the high-uptake subvolume, called "Boost," and the segmented tumor volume, called "Target." We measured several quantities that characterize the Target and Boost volumes and quantified correlations between them. Results: The behavior of the Target could not always predict the behavior of the Boost. The shape deformation of the Boost regions was on average 133% higher than that of the Target. The gross to internal target volume expansion was on average 27.4% for the Target and 64% for the Boost, a statistically significant difference (p < 0.05). Finally, the inhale-to-exhale phase (20%) had the highest shape deformation for the Boost regions. Conclusions: A complex relationship between the measured quantities for the Boost and Target volumes is revealed. The results suggest that in cases in which advanced therapy techniques such as dose painting are being used, a close examination of the 4D PET scan should be performed. (c) 2011 Elsevier Inc.
引用
收藏
页码:900 / 908
页数:9
相关论文
共 22 条
[1]   Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? [J].
Abramyuk, Andrij ;
Tokalov, Sergey ;
Zoephel, Klaus ;
Koch, Arne ;
Lazanyi, Kornelia Szluha ;
Gillham, Charles ;
Herrmann, Thomas ;
Abolmaali, Nasreddin .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :399-404
[2]   Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan [J].
Aerts, Hugo J. W. L. ;
van Baardwijk, Angela A. W. ;
Petit, Steven F. ;
Offermann, Claudia ;
van Loon, Judith ;
Houben, Ruud ;
Dingemans, Anne-Marie C. ;
Wanders, Rinus ;
Boersma, Liesbeth ;
Borger, Jacques ;
Bootsma, Gerben ;
Geraedts, Wiel ;
Pitz, Cordula ;
Simons, Jean ;
Wouters, Bradly G. ;
Oellers, Michel ;
Lambin, Philippe ;
Bosmans, Geert ;
Dekker, Andre L. A. J. ;
De Ruysscher, Dirk .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :386-392
[3]   On biologically conformal boost dose optimization [J].
Alber, M ;
Paulsen, F ;
Eschmann, SM ;
Machulla, HJ .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (02) :N31-N35
[4]   PET-GUIDED DOSE PAINTING FOR MOVING TUMORS OF THE LUNG: A PRELIMINARY ANALYSIS CONTRASTING 3D AND 4D SCANS [J].
Aristophanous, M. ;
Chen, A. ;
Yap, J. ;
Killoran, J. ;
Park, S. J. ;
Berbeco, R. .
RADIOTHERAPY AND ONCOLOGY, 2010, 94 :S12-S12
[5]   A Gaussian mixture model for definition of lung tumor volumes in positron emission tomography [J].
Aristophanous, Michalis ;
Penney, Bill C. ;
Martel, Mary K. ;
Pelizzari, Charles A. .
MEDICAL PHYSICS, 2007, 34 (11) :4223-4235
[6]   Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].
Bradley, J ;
Thorstad, WL ;
Mutic, S ;
Miller, TR ;
Dehdashti, F ;
Siegel, BA ;
Bosch, W ;
Bertrand, RJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86
[7]   A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy [J].
Chao, KSC ;
Bosch, WR ;
Mutic, S ;
Lewis, JS ;
Dehdashti, F ;
Mintun, MA ;
Dempsey, JF ;
Perez, CA ;
Purdy, JA ;
Welch, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :1171-1182
[8]   Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions [J].
Das, SK ;
Miften, MM ;
Zhou, S ;
Bell, M ;
Munley, MT ;
Whiddon, CS ;
Craciunescu, O ;
Baydush, AH ;
Wong, T ;
Rosenman, JG ;
Dewhirst, MW ;
Marks, LB .
MEDICAL PHYSICS, 2004, 31 (06) :1452-1461
[9]   Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) [J].
Erdi, YE ;
Rosenzweig, K ;
Erdi, AK ;
Macapinlac, HA ;
Hu, YC ;
Braban, LE ;
Humm, JL ;
Squire, OD ;
Chui, CS ;
Larson, SM ;
Yorke, ED .
RADIOTHERAPY AND ONCOLOGY, 2002, 62 (01) :51-60
[10]  
Eschmann SM, 2006, EUR J NUCL MED MOL I, V33, P263, DOI 10.1007/s00259-005-1953-2